Vaeck; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vaeck; Mark.The latest application filed is for "pulmonary administration of immunoglobulin single variable domains and constructs thereof".

Company Profile

0.7.15

Vaeck; Mark - Hofstade BE
Vaeck; Mark - Elewijt BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Medicinal plant extract Grant 9,901,609 - Pieters , et al. February 27, 2	2018-02-27
Pulmonary administration of immunoglobulin single variable domains and constructs thereof Grant 9,725,522 - Bouche , et al. August 8, 2	2017-08-08
Polypeptides specifically binding to IL-23 Grant 9,701,717 - Desmet , et al. July 11, 2	2017-07-11
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof App 20160280799 - BOUCHE; MARIE-PAULE LUCIENNE ARMANDA ; et al.	2016-09-29
Medicinal Plant Extract App 20160213726 - Pieters; Luc ; et al.	2016-07-28
Pulmonary administration of immunoglobulin single variable domains and constructs thereof Grant 9,320,792 - Bouche , et al. April 26, 2	2016-04-26
Polypeptide constructs including VHH directed against EGFR for intracellular delivery Grant 9,243,065 - Silence , et al. January 26, 2	2016-01-26
Polypeptides Specifically Binding To Il-23 App 20150266925 - Desmet; Johan ; et al.	2015-09-24
Binding Agents To Intracellular Target Molecules App 20140363434 - Lasters; Ignace ; et al.	2014-12-11
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof App 20130136744 - Bouche; Marie-Paule Lucienne Armanda ; et al.	2013-05-30
Method Of Administering Therapeutic Polypeptides, And Polypeptides Therefor App 20110184145 - SILENCE; KAREN ; et al.	2011-07-28
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor App 20110184151 - Laeremans; Toon ; et al.	2011-07-28
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor App 20110123529 - Laeremans; Toon ; et al.	2011-05-26
Polypeptide Constructs For Sublingual Administration App 20100040613 - Silence; Karen ; et al.	2010-02-18
Polypeptide Constructs For Intracellular Delivery App 20100021459 - Silence; Karen ; et al.	2010-01-28
Polypeptide Constructs For Topical Administration App 20100003249 - Silence; Karen ; et al.	2010-01-07
Single Domain Antibodies Directed Against Epidermal Growth Factor Receptor And Uses Therefor App 20100003253 - Laeremans; Toon ; et al.	2010-01-07
Polypeptide Constructs For Rectal And/or Vaginal Administration App 20100003248 - Silence; Karen ; et al.	2010-01-07
Polypeptide Constructs For Nasal Administration App 20090324512 - Silence; Karen ; et al.	2009-12-31
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders App 20060115470 - Silence; Karen ; et al.	2006-06-01
Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees Grant 5,300,629 - Casteels , et al. April 5, 1	1994-04-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.